Skip to main content

Peer Review reports

From: SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

Original Submission
7 May 2021 Submitted Original manuscript
18 Jul 2021 Reviewed Reviewer Report - Mateus Dias Antunes
4 Aug 2021 Reviewed Reviewer Report - Liu Jia
9 Sep 2021 Reviewed Reviewer Report - Sarah Berhane
9 Oct 2021 Author responded Author comments - Yehong Bin
Resubmission - Version 2
9 Oct 2021 Submitted Manuscript version 2
27 Oct 2021 Reviewed Reviewer Report - Sarah Berhane
7 Nov 2021 Reviewed Reviewer Report - Liu Jia
9 Dec 2021 Author responded Author comments - Yehong Bin
Resubmission - Version 3
9 Dec 2021 Submitted Manuscript version 3
10 Jan 2022 Reviewed Reviewer Report - Sarah Berhane
21 Jan 2022 Reviewed Reviewer Report - Liu Jia
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
3 Mar 2022 Editorially accepted
12 Mar 2022 Article published 10.1186/s13063-022-06143-w

You can find further information about peer review here.

Back to article page